𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Support of acute liver failure patients with a bioartificial liver

✍ Scribed by Frederick D. Watanabe; Achilles A. Demetriou

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
445 KB
Volume
11
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Imatinib mesylate as a cause of acute li
Imatinib mesylate as a cause of acute liver failure
✍ Timothy J.S. Cross; Catherine Bagot; Bernard Portmann; Julia Wendon; D. Gillett πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

A 46-year-old patient diagnosed with chronic myeloid leukemia in whom cytogenetic and molecular remission had never been achieved was commenced on Imatinib Mesylate (GleevecΓ’, Novartis Pharmaceuticals Corp., East Hanover, NJ). After 18 months of treatment, she developed abnormal liver function tests

Liver embolizations of patients with mal
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors
✍ B. K. Eriksson; E. G. Larsson; B. M. Skogseid; A. M. LΓΆfberg; L. E. LΓΆrelius; K. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## BACKGROUND. Patients with neuroendocrine gastrointestinal tumors usually present with inoperable metastatic disease and severe hormonal symptoms. Specific chemotherapy, interferon-␣ (IFN), and somatostatin analogs are established therapies for these patients, but all of them eventually fail. Hep